Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Antidepressant efficacy established with new addition to the Ampakine family

Aug. 13, 1998

Joint research project will evaluate ABS-103 for the treatment of epilepsy

Aug. 13, 1998

Sepracor patents single-isomer form of zopiclone for treatment of sleep disorders

Aug. 13, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

ADIR discovers new compounds with affinity for imidazoline receptors

Aug. 12, 1998

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Aug. 11, 1998

Studies with spheron-targeted AD treatment candidate yield promising results

Aug. 11, 1998

MABE: a new enkephalin analogue with analgesic potential

Aug. 11, 1998

New CNS agents described by French team

Aug. 11, 1998

4030W92 antihyperalgesic effect due to preferential action on slow activation state of Na+ channel

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...